Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Extended wearing trial of Trifield lens device for 'tunnel vision'.

Woods RL, Giorgi RG, Berson EL, Peli E.

Ophthalmic Physiol Opt. 2010 May;30(3):240-52. doi: 10.1111/j.1475-1313.2010.00718.x.

2.

Clinical and laboratory evaluation of peripheral prism glasses for hemianopia.

Giorgi RG, Woods RL, Peli E.

Optom Vis Sci. 2009 May;86(5):492-502. doi: 10.1097/OPX.0b013e31819f9e4d.

3.

Community-based trial of a peripheral prism visual field expansion device for hemianopia.

Bowers AR, Keeney K, Peli E.

Arch Ophthalmol. 2008 May;126(5):657-64. doi: 10.1001/archopht.126.5.657.

4.

Visual field expansion in patients with retinitis pigmentosa.

Somani S, Brent MH, Markowitz SN.

Can J Ophthalmol. 2006 Feb;41(1):27-33.

PMID:
16462868
5.

Tunnel Vision Prismatic Field Expansion: Challenges and Requirements.

Apfelbaum H, Peli E.

Transl Vis Sci Technol. 2015 Dec 31;4(6):8. eCollection 2015 Dec.

6.

Collision judgment when using an augmented-vision head-mounted display device.

Luo G, Woods RL, Peli E.

Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4509-15. doi: 10.1167/iovs.08-2916. Epub 2009 May 20.

7.

A curriculum for training patients with peripheral visual field loss to use bioptic amorphic lenses.

Laderman DJ, Szlyk JP, Kelsch R, Seiple W.

J Rehabil Res Dev. 2000 Sep-Oct;37(5):607-19.

PMID:
11322159
8.

A comparison of spectacle and contact lens wearing times in the ACHIEVE study.

Jones-Jordan LA, Chitkara M, Coffey B, Jackson JM, Manny RE, Rah MJ, Walline JJ.

Clin Exp Optom. 2010 May;93(3):157-63. doi: 10.1111/j.1444-0938.2010.00480.x.

9.

The effectivity of Fresnel prisms for visual field enhancement.

Hoppe E, Perlin RR.

J Am Optom Assoc. 1993 Jan;64(1):46-53.

PMID:
8454828
10.

Randomized crossover clinical trial of real and sham peripheral prism glasses for hemianopia.

Bowers AR, Keeney K, Peli E.

JAMA Ophthalmol. 2014 Feb;132(2):214-22. doi: 10.1001/jamaophthalmol.2013.5636.

11.

Towards an assistive peripheral visual prosthesis for long-term treatment of retinitis pigmentosa: evaluating mobility performance in immersive simulations.

Zapf MP, Boon MY, Matteucci PB, Lovell NH, Suaning GJ.

J Neural Eng. 2015 Jun;12(3):036001. doi: 10.1088/1741-2560/12/3/036001. Epub 2015 Mar 17.

PMID:
25782059
12.
13.

Red glasses and visual function in retinitis pigmentosa.

Van den Berg TJ.

Doc Ophthalmol. 1989 Nov;73(3):255-74.

PMID:
2638244
14.

A randomized controlled trial comparing soft contact lens and rigid gas-permeable lens wearing in infantile nystagmus.

Jayaramachandran P, Proudlock FA, Odedra N, Gottlob I, McLean RJ.

Ophthalmology. 2014 Sep;121(9):1827-36. doi: 10.1016/j.ophtha.2014.03.007. Epub 2014 May 6.

PMID:
24811959
15.

Progression of defects in the central 10-degree visual field of patients with retinitis pigmentosa and choroideremia.

Hirakawa H, Iijima H, Gohdo T, Imai M, Tsukahara S.

Am J Ophthalmol. 1999 Apr;127(4):436-42.

PMID:
10218696
16.

The effect of trial frames on adaptive gait.

Timmis MA, Turner K, Latham K.

Gait Posture. 2015 Jan;41(1):332-4. doi: 10.1016/j.gaitpost.2014.10.021. Epub 2014 Oct 30.

PMID:
25468681
17.

Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.

Renner AB, Kellner U, Cropp E, Preising MN, MacDonald IM, van den Hurk JA, Cremers FP, Foerster MH.

Ophthalmology. 2006 Nov;113(11):2066.e1-10. Epub 2006 Aug 28.

PMID:
16935340
18.

[Utilization of a new night vision enhancement device (DAVIS)].

Rohrschneider K, Spandau U, Wechsler S, Blankenagel A.

Klin Monbl Augenheilkd. 2000 Aug;217(2):88-93. German.

PMID:
11022662
19.

Spectacle wear in children given spectacles through a school-based program.

Messer DH, Mitchell GL, Twelker JD, Crescioni M; CLEERE Study Group.

Optom Vis Sci. 2012 Jan;89(1):19-26. doi: 10.1097/OPX.0b013e3182357f8c.

20.

Augmented-view for restricted visual field: multiple device implementations.

Vargas-Martín F, Peli E.

Optom Vis Sci. 2002 Nov;79(11):715-23.

PMID:
12462540

Supplemental Content

Support Center